Privacy Policy

Vanda Pharmaceuticals Inc. values your privacy and the security of your information. This Privacy Policy explains how Vanda ("Vanda," "we," or "us") collects and uses information obtained from users in connection with HETLIOZ.com and any of our other sites or services that link to this Privacy Policy (collectively, the "Services"). Please read the entire Privacy Policy before using our Services. By using the Services, you agree to abide by the terms of this Privacy Policy.

Information Collected.

You generally are not required to provide information about yourself when you visit the Services. However, we may ask you for some or all of the following types of information when you request additional information about Non-24-Hour Sleep-Wake Disorder (Non-24) and HETLIOZ® (tasimelteon); request tools, resources, and information about events for the blindness community; share a personal experience with Non-24 and HETLIOZ®; access various content or features; submit content; or directly contact us with questions or feedback.

  • Contact information, such as name, e-mail address, postal address, and telephone number and information about your interest in Non-24 and HETLIOZ®;
  • Demographic information, such as age information and gender;
  • Health-related information;
  • Stories, comments, and other information that you share with us;
  • Correspondence and other information that you send to us; and
  • Additional information as otherwise described to you at the point of collection or pursuant to your consent.

We also may collect certain information automatically when you visit the Services, including:

  • Your browser type and operating system;
  • Your Internet Protocol (IP) address, which is the number automatically assigned to your computer whenever you access the Internet and that can sometimes be used to derive your general geographic area;
  • Other unique identifiers, including mobile device identification numbers;
  • Sites you visited before and after visiting the Services;
  • Pages you view and links you click on within the Services;
  • Information collected through cookies, web beacons, and other technologies;
  • Information about your interactions with e-mail messages, such as the links clicked on and whether the messages were opened or forwarded; and
  • Standard Server Log Information

Use of Information.

Vanda may use information that we collect through the Services to provide you with products, promotions, services, newsletters, and information in accordance with your preferences, and to respond to correspondence that we receive from you. Sometimes, we may use the information that we collect to contact you via e-mail, telephone, or otherwise about medicines that treat Non-24, Vanda, and our products and services; to learn more about your experience with Non-24; or to otherwise provide you with information that might be of interest to you. At your election at any time, you may choose to stop receiving future communications from Vanda ("opt-out;" see below for more information on how to opt-out).

We also may use information that we collect to maintain or administer the Services, perform business analyses, or for other internal purposes to improve the quality of our business, the Services, and other products and services we offer. For example, Vanda uses information collected automatically to help diagnose problems with its server, analyze trends, and administer the Services. We also may use information that you provide to customize and personalize your use of the Services and as otherwise described to you at the point of collection or pursuant to your consent.

Sharing of Information.

We are committed to maintaining your trust, and we want you to understand when and with whom we may share the information we collect.

  • Service Providers. We may share your information with service providers that perform certain functions or services on our behalf (such as to host the Services, manage databases, perform analyses, or send communications for us).
  • Sharing Your Story with Other Users. Vanda may publish the personal experiences that you share with others via the Services and/or through any of its marketing materials. Unless otherwise agreed by you, Vanda will not use your name or e-mail address when sharing your personal experience in this way. Please note that it is not possible to opt-out of having your personal experience shared in this way after you have submitted the information via the Services. Please do not share your personal experience with Vanda unless you accept the terms of this paragraph.
  • Other Parties When Required By Law or as Necessary to Protect the Services. We may disclose information to third parties if (1) required by law or (2) we have a good faith belief that such action is necessary to conform to applicable laws or comply with any legal, regulatory or similar requirement or investigation, to protect or defend the rights or property of Vanda, our corporate parents, affiliates, and subsidiaries, or the users of our Services or to enforce the Terms of Use.
  • In Connection With a Transfer of Assets. If we sell all or part of our business, or make a sale or transfer of assets, or are otherwise involved in a merger or business transfer, or in the event of bankruptcy, we may transfer your information to one or more third parties as part of that transaction.
  • Other Parties With Your Consent. We may share information about you with third parties when you consent to such sharing.

Security.

We take a number of steps to help protect against loss, misuse, unauthorized access, disclosure, alteration or destruction of the information you provide to us. Unfortunately, no data transmission over the Internet can be guaranteed to be 100% secure. As a result, Vanda cannot ensure the security of any information you provide, and you do so at your own risk.

Children's Privacy.

The Services do not knowingly collect, use, or disclose personal information from children under the age of 13 without prior parental consent, except as permitted by the Children's Online Privacy Protection Act ("COPPA").

Third Party Sites.

The Services may permit you to link to other websites on the Internet, and other websites may contain links to the Services. These other websites are not under Vanda's control. The privacy and security practices of websites linked to or from the Services are not covered by this Privacy Policy, and Vanda is not responsible for the privacy or security practices or the content of such websites.

Cookies, Pixel Tags, and Similar Technologies.

Vanda also uses cookies, pixel tags, Local Shared Objects, and similar technologies to automatically collect certain information, such as your browser type and operating system, IP address, and other unique identifiers. "Cookies" are pieces of information that a website transfers to your computer's hard disk for record-keeping purposes. Pixel tags are very small images or small pieces of data embedded in images, also known as "web beacons" or "clear GIFs," that can recognize cookies, the time and date a page is viewed, a description of the page where the pixel tag is placed, and similar information from your computer or device. Local Shared Objects (sometimes referred to as "Flash Cookies") are similar to standard cookies except that they can be larger and are downloaded to a computer or mobile device by the Adobe Flash media player. Vanda generally uses cookies and similar technologies to determine which areas of the Services users have visited and to compare users' experiences in using the Services so that it may better tailor the Services for them. You may be able to set your web browser to refuse cookies. However, if you choose to reject cookies, you may not be able to use certain online products, services or features on the Services. Please note that you may need to take additional steps beyond changing your browser settings to refuse or disable Local Shared Objects and similar technologies. For example, Local Shared Objects can be controlled through the instructions on Adobe's Setting Manager page. By using the Services, you consent to our use of cookies and similar technologies.

We may allow third parties to place and read their own cookies, pixel tags, web beacons, Local Shared Objects, and similar technologies to collect information through the Services. For example, our third-party service providers may use these technologies to collect information that helps us with traffic measurement, research, analytics, and providing you with relevant advertisements.

Social Networking Services.

Vanda has worked with certain third-party social media providers to offer you their social networking services through our Services. For example, you can use third-party social networking services, including but not limited to Facebook, Twitter, and others to share information about your experience on our Services with your friends and followers on those social networking services. These social networking services may be able to collect information about you, including your activity on our Services. These third-party social networking services also may notify your friends, both on our Services and on the social networking services themselves, that you are a user of our Services or about your use of our Services, in accordance with applicable law and their own privacy policies. If you choose to access or make use of third-party social networking services, we may receive information about you that you have made available to those social networking services, including information about your contacts on those social networking services.

Opt-Out.

You may elect to avoid future e-mail communications from Vanda by sending an e-mail to opt-out@vandapharma.com with your electronic mail address.

Your California Privacy Rights.

Some web browsers may transmit "do-not-track" signals to the websites with which the user communicates. Because of differences in how web browsers incorporate and activate this feature, it is not always clear whether users intend for these signals to be transmitted, or whether they even are aware of them. Because there currently is no industry standard concerning what, if anything, websites should do when they receive such signals, we currently do not take action in response to these signals. If and when a final standard is established and accepted, we will reassess how to respond to these signals. In some cases, third parties may be able to collect information about a user's online activities over time and across different websites when he or she uses our Services.

Vanda does not share information that it collects with third parties for the third party's direct marketing purposes.

Changes.

Vanda reserves the right to change or update this Privacy Policy at any time by posting a notice on the Services. Information collected by the Services is subject to the Privacy Policy in effect at the time of use.

Contact.

If you have any questions regarding this Privacy Policy or the Services, please contact Vanda at: Vanda Pharmaceuticals Inc., Attn : Privacy Statement, 2200 Pennsylvania Avenue NW, Suite #300E, Washington DC 20037, Tel : 202.734.3400, E-mail : privacy@vandapharma.com

Here's Important Safety Information for
HETLIOZ® (tasimelteon).

Indication
HETLIOZ® is indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24).

Important Safety Information
HETLIOZ® (HeT-lee-ōz) is a prescription medication used to treat Non-24-Hour Sleep-Wake Disorder (Non-24).

HETLIOZ® may cause drowsiness. After taking HETLIOZ®, limit your activity to preparing for bed. HETLIOZ® can potentially impair your ability to perform activities that require complete mental alertness.

The most common side effects associated with HETLIOZ® include headache, elevated liver enzymes (ALT), nightmares or abnormal dreams, and upper respiratory or urinary tract infection. These side effects may occur more frequently in patients 65 years of age or older.

Tell your healthcare provider about all of the medicines you're taking. HETLIOZ® should not be taken in combination with fluvoxamine or rifampin.

Tell your healthcare provider about all of your health conditions, including whether you are pregnant, are planning to become pregnant, or are breastfeeding. HETLIOZ® has not been studied in pregnant women. HETLIOZ® should be used during pregnancy only if the potential benefit justifies the potential risks.

HETLIOZ® has not been studied in children and it is not recommended for use in patients with severe liver problems.

You are encouraged to report side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, call 1-800-FDA-1088, or report by fax at 1-800-FDA-0178.

For more information, ask your doctor or call 1-844-HETLIOZ (1-844-438-5469).

This information does not take the place of talking with your doctor for medical advice about your condition or treatment.

Download an accessible PDF or listen to the full Prescribing Information. You can also hear the full Prescribing Information by calling 1-844-HETLIOZ (1-844-438-5469).